Sequenom and Former CFO Resolve Litigation
March 21 2014 - 5:00PM
PR Newswire (US)
SAN DIEGO, March 21, 2014 /PRNewswire/ -- Sequenom, Inc.
(NASDAQ: SQNM), a life sciences company providing innovative
diagnostic testing and genetic analysis solutions, today announced
a resolution of litigation between the Company and Paul Hawran. Mr. Hawran served as the Company's
Chief Financial Officer from April
2007 until September 2009. Mr.
Hawran resigned in September 2009.
After September 2009, the
Securities and Exchange Commission conducted an investigation
concerning alleged inaccurate disclosures by the Company in 2008
and 2009. The Securities and Exchange Commission concluded its
investigation without any action against Mr. Hawran.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company
committed to improving healthcare through revolutionary genomic and
genetic analysis solutions. Sequenom develops innovative
technology, products and diagnostic tests that target and serve
discovery and clinical research, and molecular diagnostic markets.
Website: www.sequenom.com
Logo -
http://photos.prnewswire.com/prnh/20040415/SQNMLOGO
SOURCE Sequenom, Inc.
Copyright 2014 PR Newswire
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From May 2024 to Jun 2024
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From Jun 2023 to Jun 2024